Loading clinical trials...

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer

NCT07074535•Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

View on ClinicalTrials.gov

Summary

The goal of this observational study is to develop a predictive model for left recurrent laryngeal nerve (RLN) lymph node metastasis using deep learning algorithms. The model will be developed using clinical data from previous esophageal cancer surgeries, including preoperative CT imaging, and histopathological images from gastroscopic biopsies. The model will also be validated through prospective clinical trials to guide the intraoperative lymph node dissection, thereby reducing postoperative risks of RLN injury.

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Preoperative gastroscopic biopsy confirmed esophageal squamous cell carcinoma；
•The patient underwent esophagectomy with lymph nodes dissection along the left recurrent laryngeal nerve.

Exclusion Criteria

•The patient's medical records are incomplete；
•The patient refused to participate in the trial.

Locations (1)

Daping Hospital

Chongqing, China

Key Dates

Start Date

January 1, 2019

Primary Completion Date

July 30, 2026

Completion Date

December 30, 2027

Last Updated

July 20, 2025

Enrollment

500

ESTIMATED participants

Conditions

Esophageal Squamous Cell Cancer (SCC)Recurrent Laryngeal Nerve PalsyDeep LearningPostoperative Complication

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Advanced Solid TumorAdvanced Cancer+20 more

View study

RECRUITING

Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study

NCT07111364

Deep LearningUltrasound+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer

Inclusion Criteria

Exclusion Criteria

A Study of MGC026 in Participants With Advanced Solid Tumors

Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

The Construction and Effect Verification of a Deep Learning-based Automated Semantic Segmentation Model for Medical Imaging

Artificial Intelligence in Detecting Cardiac Function

Ga-68 Dolacga PET Scan in HCC Under RFA